Drug intelligence / Profile preview

Juan Bi Pill + methotrexate

Development stage
Unknown
Lead developer
Professor Liangchun Zhu
Modality
Small Molecules
Administration
Oral, Subcutaneous, Intramuscular
01

Overview

Juan Bi Pill + methotrexate is a combination therapy consisting of Yi Shen Juan Bi Pill (YSJB), a traditional Chinese herbal compound, and methotrexate (MTX), a conventional disease-modifying antirheumatic drug. This combination has been studied primarily for the treatment of rheumatoid arthritis (RA). Methotrexate acts as an anchor drug in RA management by inhibiting osteoclastogenesis and inflammation. Yi Shen Juan Bi Pill is composed of 20 medicinal herbs and has been used extensively in China to treat RA, particularly in patients with kidney deficiency patterns according to traditional Chinese medicine. Mechanistically, YSJB modulates immune responses by regulating T cell phenotypes—upregulating regulatory T cells (Tregs) while downregulating Th1 and Th17 cells—and influences cytokine production such as IL-6, IL-17A, IL-10, and TGF-β1. Both agents inhibit osteoclast differentiation and bone resorption; however, MTX is more effective at inhibiting RANK expression than YSJB alone. The combination aims to enhance efficacy for patients who do not respond adequately to monotherapy[2][3][5].

Other names
Yi Shen Juan Bi Pill + methotrexateYSJB + MTXJuanbi pill combined with methotrexate
02

Targets

DHFR (Dihydrofolate reductase)IL-17A (Interleukin-17A)

Beyond the preview

Go deeper on Juan Bi Pill + methotrexate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Juan Bi Pill + methotrexate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call